Additionally, new urinary biomarkers associated to predisposition to AKI have been identified in animal models, including ganglioside M2 activator protein (GM2AP) [118], fumarylacetoacetase (FAA) [116], hemopexin [115], transferrin [115,117], albumin [115,129] and the vitamin D binding protein (VDBP) [115]. This evidence concerns the gene GM2A and acute kidney injury.